Evolent Health, Inc.
DE ˙ DB ˙ US30050B1017
3,38 € ↓ -0,16 (-4,52%)
2026-06-03
DEL PRIS
SecurityDE:9EH / Evolent Health, Inc.
InstitutionXTX Topco Ltd
Latest Disclosed Ownership283,518 shares
Latest Disclosed Value $ 646,421
XTX Topco Ltd reports 356.42% increase in ownership of 9EH / Evolent Health, Inc.

On May 15, 2026 - XTX Topco Ltd filed a 13F-HR form disclosing ownership of 283,518 shares of Evolent Health, Inc. (DE:9EH) valued at $535,849 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 62,118 shares of Evolent Health, Inc.. This represents a change in shares of 356.42% during the quarter. The current value of the position is $958,291 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EVOLENT HEALTH CL A 30050B101 283,518 221,400 356.42 646 160.48 0.0112
2026-02-17 2025-12-31 13F EVOLENT HEALTH CL A 30050B101 62,118 -35,838 -36.59 248 -70.05 0.0065
2025-11-14 2025-09-30 13F EVOLENT HEALTH CL A 30050B101 97,956 21,051 27.37 829 -4.28 0.0430
2025-08-12 2025-06-30 13F EVOLENT HEALTH CL A 30050B101 76,905 33,697 77.99 866 111.49 0.0359
2025-05-08 2025-03-31 13F EVOLENT HEALTH CL A 30050B101 43,208 19,887 85.28 409 56.11 0.0209
2025-02-13 2024-12-31 13F EVOLENT HEALTH CL A 30050B101 23,321 9,731 71.60 262 -31.77 0.0216
2024-11-14 2024-09-30 13F EVOLENT HEALTH CL A 30050B101 13,590 -29,791 -68.67 384 -53.68 0.0278
2024-08-12 2024-06-30 13F EVOLENT HEALTH CL A 30050B101 43,381 23,917 122.88 829 29.94 0.0710
2024-05-13 2024-03-31 13F EVOLENT HEALTH CL A 30050B101 19,464 19,464 638 0.0860
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.